Compared with the normal control group, the mRNA levels of NLRP3, NFE2L2, and NFKB1 in the diabetes model group were significantly increased, while they decreased in the SAL treatment group (P < 0.05), with the statistical difference. The gene discussed is NFE2L2; the disease is diabetes mellitus.